Nomura Holdings
XGN icon

Nomura Holdings’s Exagen XGN Stock Holding History

Nomura Holdings’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-355,000
Closed -$5.33M – 2254
2021
Q2 		$5.33M Hold
355,000
– – 0.01% 556
2021
Q1 		$6.2M Buy
355,000
+4,000
+1% +$71.3K 0.01% 482
2020
Q4 		$4.51M Buy
351,000
+4,200
+1% +$59.3K 0.01% 606
2020
Q3 		$3.98M Buy
+346,800
New +$4.47M 0.01% 522

Other funds holding XGN

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

Nomura Holdings's XGN Position: Q3 2021 in Review

Nomura Holdings sold out of Exagen (XGN) in Q3 2021, closing a stake of 355,000 shares — an estimated $5.33M sold.

Nomura Holdings first reported a position in XGN in Q3 2020 and held it in 4 quarters. The position peaked at $6.2M in Q1 2021. 53 funds tracked by Wall St. Rank hold XGN as of Q3 2021.

  • Nomura Holdings reported no remaining Exagen position as of Q3 2021 after selling out during the quarter.
  • Nomura Holdings sold 355,000 Exagen shares in Q3 2021, an estimated $5.33M.
  • Nomura Holdings first reported a position in Exagen in Q3 2020 and held it in 4 quarters.
  • Nomura Holdings's Exagen position peaked at $6.2M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Exagen as of Q3 2021.

Based on Nomura Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.